Author name: Leonardo Arias

Venture funds attending the J.P. Morgan Healthcare Conference said mounting funding pressures and Chinese competition have sharpened their focus on leadership qualities, from regulatory expertise and industry experience to the ability to scale—or step aside—as companies mature.

The U.S. spent 7.2% more on healthcare in 2024. Most of the acceleration was because of greater use and intensity of medical goods and services, not growth in healthcare prices, CMS actuaries said.

Primarily known as an immunology and neuroscience company, AbbVie wanted to put the biopharma world on notice during its J.P. Morgan presentation: its oncology portfolio is underappreciated. This week, the Illinois-based company dove into the sizzling PD-1/VEGF space with a licensing deal with China-based RemeGen.

The insurer will cut its MA payment timelines in half for select providers in Oklahoma, Idaho, Minnesota and Missouri in an effort to provide relief to rural hospitals.

Buying vaccine biotech Dynavax was an easy choice for Sanofi despite antivaccine moves by the Trump administration.

At a J.P. Morgan media event Tuesday, the Gilead C-suite seemed to be walking on air as they highlighted Yeztugo’s capture of the HIV market and its plans for business development.

Workers at the National Institute for Occupational Safety and Health affected by the layoffs last spring received emails yesterday that their reduction-in-force notices have been revoked. Hundreds of NIOSH employees had been let go.

The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.

Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with Eli Lilly and its Kisunla offering—is focused on a near-term FDA decision for a subcutaneous induction dose of Leqembi, a presymptomatic readout in 2028 and a clutch of next-generation candidates.

  Cuando hace años un reconocido jugador se enfrentó por primera vez a una plataforma online, y siempre surgía la misma duda: ¿realmente entendemos qué es el azar cuando todo pasa en una pantalla y un servidor decide todo en segundos? Antes, en los casinos …